Navigation Links
Lawmakers Agree to Ban Dangerous Chemicals in Toys
Date:7/29/2008

Major milestone reached for children's health and for chemical regulation

WASHINGTON, July 29 /PRNewswire-USNewswire/ -- Lawmakers charged with finalizing the Consumer Product Safety Commission Reform Act agreed yesterday to include a provision that will ban phthalates from children's toys and childcare articles. The legislative action validates the concerns of scientists and parents who have been urging a ban, and will bring federal regulation in line with several states and leading retailers that have already taken action to remove phthalates from toys.

Phthalates are chemical substances used to make plastic toys like rubber ducks and bath books soft and flexible. When children put these toys in their mouths, the phthalates can easily leach from toy to child. Phthalates have been linked to serious health concerns including birth defects, early puberty in girls (a risk factor for breast cancer) and liver cancer.

Retailers and manufacturers including Wal-Mart, Toys-R-Us, Lego, Evenflo and Gerber have announced plans to phase out phthalates. California, Washington and Vermont have passed laws restricting phthalate use in children's products. Phthalates are also banned or restricted in the European Union and more than a dozen countries around the world.

"This legislation is a victory for children's health and safety," said Janet Nudelman, director of program and policy at the Breast Cancer Fund, "and a major blow to the chemical industry, which spent millions of dollars trying to defeat it. Congress took a first, important step toward reforming the way chemicals are regulated in this country. It's a great start and an indication that our lawmakers are ready to consider the kind of sweeping reform that's needed."

The broad-based national effort that convinced Congress to consider the phthalates ban points to a growing movement of parents, health care professionals, and environmental health and breast cancer prevention advocates
'/>"/>

SOURCE Breast Cancer Fund
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hospitals and the Coalition to Protect Floridas Drivers Applaud Lawmakers for Reviving No-Fault Insurance
2. 273 Lawmakers Put Kids First
3. AARP CEO Bill Novelli Tells Lawmakers: Controlling Health Care Costs Key to Budget Reform
4. Susan G. Komen for the Cure, State Lawmakers, Breast Cancer Survivors, Celebrities and Activists Call on Legislature to Strengthen Breast Cancer Screening Program for Underserved Women
5. Ad Campaign Urges Pennsylvania Lawmakers to Stop Waffling and Pass Comprehensive Smoke-Free Law
6. California Lawmakers Unveil Legislative Effort on Autism
7. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 2Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 3Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 4Health News:Medical Blogs May Threaten Patient Privacy 2Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 2Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 3Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 4Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 5Health News:Vapotherm(R) Precision Flow(TM) Receives FDA 510(k) Clearance 2Health News:Consumers, Nurses, Seniors Tell Governor: Don't Break Your Promise to Protect Innocent Patients from Health Insurance Cancellations, Don't Weaken Existing Law 2Health News:Consumers, Nurses, Seniors Tell Governor: Don't Break Your Promise to Protect Innocent Patients from Health Insurance Cancellations, Don't Weaken Existing Law 3Health News:Consumers, Nurses, Seniors Tell Governor: Don't Break Your Promise to Protect Innocent Patients from Health Insurance Cancellations, Don't Weaken Existing Law 4Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 2Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 3Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 4Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 5Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 6
Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Vivakor Announces New Acquisition Strategy 2General anesthetics lead to learning disabilities in animal models 59954 1General anesthetics lead to learning disabilities in animal models 59954 2General anesthetics lead to learning disabilities in animal models 59954 3New artificial enzyme safer for nature 10482 1New artificial enzyme safer for nature 10482 2Now hear this 10478 1